Saturday 17 October 2026
Export HSIC’s income statement to Excel — free account
Henry Schein, Inc.
HSIC Healthcare Medical Distribution
Henry Schein, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.2 billion, up 4.03% from fiscal 2024. In the quarter to June 2026, revenue grew 6.73%, EPS grew 16.9%, free cash flow grew 140.9% and total debt rose 15.2%, each against the same quarter a year earlier. Member of the S&P 500; insiders bought in the last twelve months.
86.38
0.61
−0.70%
Follow HSIC
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
24.14 | 22.07 | 22.90 | 20.81 |
+8 more quarters Free account |
P/S ratio |
0.70 | 0.63 | 0.69 | 0.62 | |
P/FCF ratio |
16.65 | 19.04 | 15.94 | 19.80 | |
P/Operating CF |
39.15 | (87.33) | 23.97 | 45.85 | |
P/B ratio |
2.48 | 2.16 | 2.34 | 1.98 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.86 | 0.80 | 0.86 | 0.77 | |
EV/EBITDA |
11.69 | 10.94 | 11.74 | 10.42 | |
EV/Operating CF |
16.79 | 18.50 | 15.90 | 18.74 | |
EV/FCF |
20.66 | 24.03 | 19.75 | 24.88 | |
Quick Ratio |
0.55 | 0.56 | 0.56 | 0.60 | |
Current Ratio |
1.32 | 1.36 | 1.38 | 1.40 | |
Net Debt/EBITDA |
8.95 | 8.46 | 8.93 | 8.42 | |
Debt/Assets |
21.42% | 20.90% | 20.89% | 19.67% | |
Debt/Equity |
0.64 | 0.60 | 0.60 | 0.54 | |
Asset Turnover |
1.22 | 1.23 | 1.23 | 1.19 | |
Operating CF/Net income |
2.57 | (0.91) | 3.77 | 1.72 | |
Capex/Depreciation |
(0.36) | (0.31) | (0.52) | (0.42) | |
Interest Coverage |
3.98 | 4.67 | 4.18 | 4.32 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
24.03% | 24.02% | 23.51% | 22.76% | |
Intangible Assets out of Total Assets |
0.46 | 0.47 | 0.47 | 0.47 | |
Share Based Compensation of Revenue |
0.38% | 0.09% | 0.29% | 0.39% | |
Graham Net Nets |
(0.31) | (0.34) | (0.31) | (0.34) | |
Graham Number |
51.18 | 50.62 | 48.95 | 49.01 | |
Earnings Yield |
4.14% | 4.53% | 4.37% | 4.81% | |
Free Cash Flow Yield |
6.01% | 5.25% | 6.28% | 5.05% | |
Revenue per Share |
30.48 | 29.30 | 28.45 | 27.78 | |
Operating CF per Share |
2.13 | (0.84) | 3.15 | 1.45 | |
Capex per Share |
(0.26) | (0.22) | (0.36) | (0.27) | |
Free Cash Flow per Share |
1.87 | (1.06) | 2.80 | 1.17 | |
Cash per Share |
1.38 | 1.20 | 1.29 | 1.13 | |
Shareholders Equity per Share |
33.64 | 34.10 | 32.27 | 33.47 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
33.64 | 34.10 | 32.27 | 33.47 | |
Free Cash Flow |
212.00 | (122.00) | 338.00 | 141.00 | |
Working Capital |
1,112.00 | 1,199.00 | 1,236.00 | 1,246.00 | |
Capital Expenditures |
(30.00) | (25.00) | (43.00) | (33.00) | |
Net Current Asset Value |
(2,964.00) | (2,889.00) | (2,852.00) | (2,679.00) | |
EV/EBIT |
17.29 | 16.20 | 17.33 | 15.54 | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Price to Operating Income |
13.93 | 12.84 | 13.98 | 12.37 | |
| Other line items | |||||
Average Receivables |
1,704.00 | 1,648.50 | 1,566.50 | 1,701.50 | |
Average Payables |
1,026.50 | 975.50 | 1,058.00 | 1,030.50 | |
Average Inventory |
1,983.50 | 1,928.00 | 1,906.00 | 1,833.00 | |
Average Assets |
11,143.50 | 10,892.00 | 10,716.50 | 10,851.00 | |
Average Common Equity |
3,952.50 | 3,936.50 | 3,965.00 | 4,081.00 |
Columns are period end dates